FDA reportedly eyeing staff bonuses to accelerate drug reviews
The U.S. Food and Drug Administration (FDA) is launching a bonus scheme for its scientific staff who complete drug reviews...
Tag: ABT
Abbott eyes $20B bond sale to fund purchase of Exact Sciences – report
Abbott Laboratories (ABT) is seeking to raise nearly $20B through a sale of bonds to finance its previously announced...
Abbott Laboratories declares $0.63 dividend
Abbott Laboratories (ABT) declares $0.63/share quarterly dividend, in line with previous. Forward yield 2.26% Payable May...
NIH director reportedly being tapped as acting CDC director
The director of the National Institutes of Health (NIH), Jay Bhattacharya, is expected to take on an additional role as the...
Insider trades: Merck, Intel, Micron among notable names
A weekly overview of insider trading, highlighting significant purchases and sales by investors, directors, and executives....
Exact Sciences ticks higher amid reports HSR for Abbott deal expired
Exact Sciences (EXAS) edged higher by 0.5% amid reports the HSR waiting period for its planned sale to Abbott Laboratories...
Abbott glucose monitor sensor recall classified as most serious by FDA
The U.S. Food and Drug Administration (FDA) on Wednesday categorized a product recall initiated by Abbott Laboratories (ABT)...
Abbott Laboratories snaps six straight sessions of losses
Abbott Laboratories (ABT) shares snapped six straight sessions of losses, as the stock closed 1.2% higher at $108.77 on...
Abbott CEO purchases $2M worth of company shares
Abbott Laboratories (ABT) Chairman and CEO Robert Ford purchased 18.8K of company stock recently with a value of just over...
Abbott projects 7% organic sales growth and 10% EPS rise for 2026 as Nutrition pivots to volume recovery
Earnings Call Insights: Abbott Laboratories (ABT) Q4 2025 CEO Robert Ford highlighted that 2025 showcased "Abbott's...